Serum antibody response to active infection withCryptococcus neoformansand its varieties in immunocompetent subjects
- 1 January 1996
- journal article
- Published by Oxford University Press (OUP) in Medical Mycology
- Vol. 34 (3) , 187-193
- https://doi.org/10.1080/02681219680000311
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Clinical and Host Differences Between Infections with the Two Varieties of Cryptococcus neoformansClinical Infectious Diseases, 1995
- Cryptococcal Disease of the CNS in Immunocompetent Hosts: Influence of Cryptococcal Variety on Clinical Manifestations and OutcomeClinical Infectious Diseases, 1995
- Mouse-human immunoglobulin G1 chimeric antibodies with activities against Cryptococcus neoformansAntimicrobial Agents and Chemotherapy, 1994
- Therapeutic efficacy of monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan alone and in combination with amphotericin BAntimicrobial Agents and Chemotherapy, 1994
- Cryptococcus neoformans Antibody Levels in Patients with AIDSScandinavian Journal of Infectious Diseases, 1988
- Cryptococcal Disease in Patients with the Acquired Immunodeficiency SyndromeAnnals of Internal Medicine, 1986
- EPIDEMIOLOGIC DIFFERENCES BETWEEN THE TWO VARIETIES OF CRYPTOCOCCUS NEOFORMANS1American Journal of Epidemiology, 1984
- Long-lasting, specific immunologic unresponsiveness associated with cryptococcal meningitis.Journal of Clinical Investigation, 1982
- Development of an enzyme immunoassay for cryptococcal antibodyMycopathologia, 1980
- Serologic tests in diagnosis and prognosis of cryptococcosisJAMA, 1966